Sinus venosus atrial septal defect

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Sinus venosus atrial septal defect | |
|---|---|
| Synonyms | Sinus venosus ASD |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Shortness of breath, fatigue, heart palpitations, heart murmur |
| Complications | Pulmonary hypertension, heart failure, atrial fibrillation |
| Onset | Congenital (present at birth) |
| Duration | Lifelong unless treated |
| Types | N/A |
| Causes | Congenital heart defect |
| Risks | Genetic factors, family history |
| Diagnosis | Echocardiogram, cardiac MRI, chest X-ray |
| Differential diagnosis | Atrial septal defect, ventricular septal defect, patent foramen ovale |
| Prevention | N/A |
| Treatment | Surgical repair, cardiac catheterization |
| Medication | N/A |
| Prognosis | Good with treatment |
| Frequency | Rare |
| Deaths | Rare with treatment |
Sinus venosus atrial septal defect (SVASD) is a form of atrial septal defect (ASD), which is a congenital heart defect characterized by an abnormal opening in the atrial septum, the wall that divides the two upper chambers of the heart (the atria). Unlike the more common secundum atrial septal defects, sinus venosus defects are located near the junction of the superior vena cava (SVC) and the right atrium, either above (superior) or occasionally near the inferior vena cava (inferior SVASD).
Etiology and Pathophysiology[edit]
The development of SVASD is related to abnormal embryological development of the sinus venosus, an embryonic precursor to part of the right atrium and the venous return pathways including the SVC and the inferior vena cava (IVC). This defect results in a shunting of blood from the higher pressure left atrium to the lower pressure right atrium, leading to an increased volume of blood flow through the lungs. Over time, this can cause enlargement of the right atrium and right ventricle, increased pulmonary artery pressure, and may lead to heart failure and pulmonary hypertension.
Clinical Presentation[edit]
Patients with SVASD may be asymptomatic or present with symptoms related to the volume overload on the right side of the heart. Symptoms can include shortness of breath, especially during exertion, fatigue, palpitations, and in more severe cases, signs of heart failure such as swelling of the legs or abdomen. Physical examination may reveal a systolic murmur due to increased flow across the pulmonary valve.
Diagnosis[edit]
Diagnosis of SVASD involves imaging studies to visualize the defect and assess its effects on heart structure and function. Echocardiography is the primary diagnostic tool, often supplemented by cardiac MRI or CT for detailed anatomical assessment. These imaging studies can help differentiate SVASD from other types of ASD and evaluate for associated anomalies, such as anomalous pulmonary venous return.
Treatment[edit]
The treatment for SVASD typically involves surgical repair, especially in symptomatic patients or those with evidence of right heart enlargement or dysfunction. The goal of surgery is to close the defect and, if necessary, redirect anomalous pulmonary venous return to the left atrium. Surgical intervention is generally recommended to prevent long-term complications such as pulmonary hypertension and heart failure.
Prognosis[edit]
With timely and appropriate surgical intervention, the prognosis for individuals with SVASD is generally good. Most patients can expect a normal life expectancy and significant improvement in symptoms. However, long-term follow-up is necessary to monitor for potential complications, such as arrhythmias or pulmonary hypertension, even after successful repair.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
